Botulinum Toxin Treatment for Pain and Inflammation in Functional Urological Disorders

• Andere auteurs: Kuo, Hann-Chorng (Redacteur)
• Formaat: Elektronisch Hoofdstuk
• Taal: Engels
• Gepubliceerd in: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
• Onderwerpen: Medicine; urethra; onabotulinumtoxinA; voiding; therapeutic outcome; lower urinary tract symptoms; botulinum toxin; benign prostatic hyperplasia; prostatitis; inflammation; Botulinum toxin; chronic prostatitis; interstitial cystitis; treatment; bladder pain; botulinum toxin A; predictor; maximal bladder capacity; hydrodistention; urethral sphincter; urethral sphincter dysfunction; urodynamics; drug delivery; overactive bladder; painful bladder syndrome; molecular mechanism; chronic pelvic pain syndrome; pelvic pain; functional urology disorder; human; network meta-analysis; OnabotulinumtoxinA; peripheral tibial nerve stimulation; sacral neuromodulation; bladder; sensation; therapy; pathophysiology; diabetes mellitus; mid-urethral sling; antimuscarinics; urinary incontinence; functional urological disorders; pain; neurogenic detrusor overactivity
• Online toegang: DOAB: download the publication; DOAB: description of the publication

The botulinum toxin has been widely applied in the treatment of functional urological diseases, such as overactive bladder, neurogenic detrusor overactivity, interstitial cystitis, and chronic pelvic pain syndrome. Evidence has shown that the botulinum toxin not only affects the release of neuropept...